KMI
69
-2
MCHP
34
-2
SPG
60
2
SEE
53
3
DOV
65
-4
VMC
53
-4
AAP
35
-9
JNJ
41
3
ADP
65
-3
MAS
52
-4
MMM
35
-5
AME
74
-4
FRT
41
-2
ABT
59
2
CVX
43
-3
NEE
54
7
EOG
56
-2
MDLZ
32
-4
BXP
49
-3
DG
8
-2
KMI
69
-2
MCHP
34
-2
SPG
60
2
SEE
53
3
DOV
65
-4
VMC
53
-4
AAP
35
-9
JNJ
41
3
ADP
65
-3
MAS
52
-4
MMM
35
-5
AME
74
-4
FRT
41
-2
ABT
59
2
CVX
43
-3
NEE
54
7
EOG
56
-2
MDLZ
32
-4
BXP
49
-3
DG
8
-2
Financhill
Back

ClearBridge Sustainable Infras ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
20

INFR
ClearBridge Sustainable Infras ETF

Last Price:
24.25
Seasonality Move:
2.91%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
20
ClearBridge Sustainable Infras ETF (INFR) is a Sell

Is ClearBridge Sustainable Infras ETF a Buy, Sell or Hold?

  • The current ClearBridge Sustainable Infras ETF [INFR] share price is $24.08. The Score for INFR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • INFR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INFR Stock Price Chart

What is ClearBridge Sustainable Infras ETF's stock price today?

  • The ClearBridge Sustainable Infras ETF share price today is $24.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INFR is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

INFR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 31.08 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.31 - 25.51) Sell
Bollinger Bands (100): (24.19 - 25.91) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

INFR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.2 Sell
20-day SMA: 24.7 Sell
50-day SMA: 25.47 Sell
200-day SMA: 24.36 Sell
8-day EMA: 24.29 Sell
20-day EMA: 24.65 Sell
50-day EMA: 25.04 Sell
200-day EMA: 24.67 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

ClearBridge Sustainable Infras ETF Earnings Growth & INFR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

ClearBridge Sustainable Infras ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):